Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Ifosfamide × 30 days × Clear all

Sponsor

Conditions

Sarcoma 3 Lymphoma, Large B-Cell, Diffuse 3 Sarcoma, Ewing 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Wilms Tumor 1 Teratoma 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Perivascular Epithelioid Cell Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nerve Sheath Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lymphoma 1 Liposarcoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Biphenotypic, Acute 1 Leiomyosarcoma 1 Ichthyosis, X-Linked 1 Hodgkin Disease 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Granuloma, Plasma Cell 1 Fibrosarcoma 1

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡